 | • レポートコード：MRC2305A131 • 出版社/出版日：Transparency Market Research / 2023年3月28日 • レポート形態：英文、PDF、183ページ • 納品方法：Eメール（納期：要問合せ） • 産業分類：医療機器 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本市場調査資料によると、世界のモバイル型心臓テレメトリーデバイス市場規模が、2023年の942.7百万ドルから2031年には25億ドルまで年平均11.6%成長すると見込まれています。本資料はモバイル型心臓テレメトリーデバイスの世界市場について広く調査し、序論、仮定、調査方法、エグゼクティブサマリー、市場概要、新型コロナウイルス感染症分析、用途別（リードベース、パッチベース）分析、疾患別（狭心症、動脈硬化、心不全、その他）分析、エンドユーザー別（病院、専門クリニック、診療所、在宅医療、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、主要ポイントなどをまとめています。また、本資料には、BioTelemetry, Inc.、ScottCare、Biotricity, Inc.、Welch Allyn、Applied Cardiac Systems, Inc.、Medicomp, Inc.、Preventice Solutions、Telerhythmics LLC、Zoll Medical Corporation、iRhythm Technologies, Inc.などの企業情報が含まれています。 ・序論 ・仮定 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・新型コロナウイルス感染症分析 ・世界のモバイル型心臓テレメトリーデバイス市場規模：用途別 - リードベースにおける市場規模 - パッチベースにおける市場規模 ・世界のモバイル型心臓テレメトリーデバイス市場規模：疾患別 - 狭心症における市場規模 - 動脈硬化における市場規模 - 心不全における市場規模 - その他疾患における市場規模 ・世界のモバイル型心臓テレメトリーデバイス市場規模：エンドユーザー別 - 病院における市場規模 - 専門クリニックにおける市場規模 - 診療所における市場規模 - 在宅医療における市場規模 - その他エンドユーザーにおける市場規模 ・世界のモバイル型心臓テレメトリーデバイス市場規模：地域別 - 北米のモバイル型心臓テレメトリーデバイス市場規模 - ヨーロッパのモバイル型心臓テレメトリーデバイス市場規模 - アジア太平洋のモバイル型心臓テレメトリーデバイス市場規模 - 中南米のモバイル型心臓テレメトリーデバイス市場規模 - 中東・アフリカのモバイル型心臓テレメトリーデバイス市場規模 ・競争状況 ・企業情報 |
Mobile Cardiac Telemetry Device Market – Scope of Report
TMR’s report on the global mobile cardiac telemetry device market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global mobile cardiac telemetry device market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global mobile cardiac telemetry device market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the mobile cardiac telemetry device market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global mobile cardiac telemetry device market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global mobile cardiac telemetry device market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global mobile cardiac telemetry device market.
The report delves into the competitive landscape of the global mobile cardiac telemetry device market. Key players operating in the global mobile cardiac telemetry device market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global mobile cardiac telemetry device market profiled in this report.
Key Questions Answered in Global Mobile Cardiac Telemetry Device Market Report
• What is the sales/revenue generated by mobile cardiac telemetry device across all regions during the forecast period?
• What are the opportunities in the global mobile cardiac telemetry device market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
Mobile Cardiac Telemetry Device Market – Research Objectives and Research Approach
The comprehensive report on the global mobile cardiac telemetry device market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global mobile cardiac telemetry device market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global mobile cardiac telemetry device market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Mobile Cardiac Telemetry Device Market
4. Market Overview
4.1. Introduction
4.1.1. Disease Indication Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Technological Advancement
5.2. Regulatory Analysis
5.3. Disease Incidence and Prevalence
5.4. COVID-19 Impact Analysis
6. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Application, 2017 – 2031
6.3.1. Lead-based
6.3.2. Patch-based
6.4. Market Attractiveness Analysis, by Application
7. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Disease Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Disease Indication, 2017–2031
7.3.1. Angina Pectoris
7.3.2. Atherosclerosis
7.3.3. Heart Failure
7.3.4. Others
7.4. Market Attractiveness, by Disease Indication
8. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Diagnostic Centers
8.3.4. Home Care Settings
8.3.5. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Mobile Cardiac Telemetry Device Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Application, 2017–2031
10.2.1. Lead-based
10.2.2. Patch-based
10.3. Market Value Forecast, by Disease Indication, 2017–2031
10.3.1. Angina Pectoris
10.3.2. Atherosclerosis
10.3.3. Heart Failure
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Specialty Clinics
10.4.3. Diagnostic Centers
10.4.4. Home Care Settings
10.4.5. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Application
10.6.2. By Disease Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Mobile Cardiac Telemetry Device Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Application, 2017–2031
11.2.1. Lead-based
11.2.2. Patch-based
11.3. Market Value Forecast, by Disease Indication, 2017–2031
11.3.1. Angina Pectoris
11.3.2. Atherosclerosis
11.3.3. Heart Failure
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Diagnostic Centers
11.4.4. Home Care Settings
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Application
11.6.2. By Disease Indication
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Mobile Cardiac Telemetry Device Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Application, 2017–2031
12.2.1. Lead-based
12.2.2. Patch-based
12.3. Market Value Forecast, by Disease Indication, 2017–2031
12.3.1. Angina Pectoris
12.3.2. Atherosclerosis
12.3.3. Heart Failure
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Specialty Clinics
12.4.3. Diagnostic Centers
12.4.4. Home Care Settings
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Application
12.6.2. By Disease Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Mobile Cardiac Telemetry Device Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Application, 2017–2031
13.2.1. Lead-based
13.2.2. Patch-based
13.3. Market Value Forecast, by Disease Indication, 2017–2031
13.3.1. Angina Pectoris
13.3.2. Atherosclerosis
13.3.3. Heart Failure
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Specialty Clinics
13.4.3. Diagnostic Centers
13.4.4. Home Care Settings
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Application
13.6.2. By Disease Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Mobile Cardiac Telemetry Device Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Application, 2017–2031
14.2.1. Lead-based
14.2.2. Patch-based
14.3. Market Value Forecast, by Disease Indication, 2017–2031
14.3.1. Angina Pectoris
14.3.2. Atherosclerosis
14.3.3. Heart Failure
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Specialty Clinics
14.4.3. Diagnostic Centers
14.4.4. Home Care Settings
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. Brazil
14.5.2. Mexico
14.5.3. Rest of Latin America
14.6. Market Attractiveness Analysis
14.6.1. By Application
14.6.2. By Disease Indication
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2022
15.3. Company Profiles
15.3.1. BioTelemetry, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Test Application Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. ScottCare
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Test Application Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Biotricity Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Test Application Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Welch Allyn
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Test Application Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Applied Cardiac Systems, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Test Application Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Medicomp, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Test Application Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Preventice Solutions
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Test Application Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Telerhythmics LLC
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Test Application Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Zoll Medical Corporation
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Test Application Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. iRhythm Technologies, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Test Application Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview